Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease

Neuroscience Letters

Volumn 391, Issue 3, 2006, Pages 142-146

  Shibata, Nobuto ^a   Kawarai, Toshitaka ^a   Lee, Joseph H ^b   Lee, Hye Seung ^b   Shibata, Eri ^a   Sato, Christine ^a   Liang, Yan ^a   Duara, Rajan ^c   Mayeux, Richard P ^b,d   St George Hyslop, Peter H ^a,e   Rogaeva, Ekaterina ^a,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d University Health Network ^*  (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Cholesterol; Risk factor; Single nucleotide polymorphism

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; CHOLESTEROL 24 HYDROXYLASE; CHOLESTEROL 25 HYDROXYLASE; CHOLESTEROL DERIVATIVE; OXYGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE INTERACTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; ATP-BINDING CASSETTE TRANSPORTERS; CARIBBEAN REGION; CHOLESTEROL; FEMALE; FLORIDA; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; MALE; ONTARIO; PHENOTYPE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STATISTICS; STEROID HYDROXYLASES;

EID: 28444470503     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.08.048     Document Type: Article

References (17)

1. G.R. Abecasis, and W.O. Cookson GOLD - graphical overview of linkage disequilibrium Bioinformatics 16 2000 182 183
2. B. Borroni, S. Archetti, C. Agosti, N. Akkawi, C. Brambilla, L. Caimi, C. Caltagirone, M. Di Luca, and A. Padovani Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators Neurobiol. Aging 25 2004 747 751
3. B. Devlin, and N. Risch A comparison of linkage disequilibrium measures for fine-scale mapping Genomics 29 1995 311 322
4. T. Hartmann, and Cholesterol A beta and Alzheimer's disease Trends. Nueosci. 11 Suppl. 2001 45 48
5. H. Katzov, K. Chalmers, J. Palmgren, N. Andreasen, B. Johansson, N.J. Cairns, M. Gatz, G.K. Wilcock, S. Love, N.L. Pedersen, A.J. Brookes, K. Blennow, P.G. Kehoe, and J.A. Prince Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism Hum. Mutat. 23 4 2004 358 367
6. H. Kolsch, D. Lutjohann, M. Ludwig, A. Schulte, U. Ptok, F. Jessen, K. von Bergmann, M.L. Rao, W. Maier, and R. Heun Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease Mol. Psychiatry 7 2002 899 902
7. J.H. Lee, R. Mayeux, D. Mayo, J. Mo, V. Santana, J. Williamson, A. Flaquer, A. Ciappa, H. Rondon, P. Estevez, R. Lantigua, T. Kawarai, A. Toulina, M. Medrano, M. Torres, Y. Stern, B. Tycko, E. Rogaeva, P.H. St George-Hyslop, and J.A. Knowles Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics Mol. Psychiatry 9 2004 1042 1051
8. E.G. Lund, T.A. Kerr, J. Sakai, W.P. Li, and D.W. Russell cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism J. Biol. Chem. 273 51 1998 34316 34327
9. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
10. A. Myers, F. Wavrant De-Vrieze, P. Holmans, M. Hamshere, R. Crook, D. Compton, H. Marshall, D. Meyer, S. Shears, J. Booth, D. Ramic, H. Knowles, J.C. Morris, N. Williams, N. Norton, R. Abraham, P. Kehoe, H. Williams, V. Rudrasingham, F. Rice, P. Giles, N. Tunstall, L. Jones, S. Lovestone, J. Williams, M.J. Owen, J. Hardy, and A. Goate Full genome screen for Alzheimer disease: stage II analysis Am. J. Med. Genet. 114 2002 235 244
11. S. Purcell, S.S. Cherny, and P.C. Sham Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits Bioinformatics 19 2003 149 150
12. D. Rabinowitz, and N. Laird A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information Hum. Hered. 50 2000 211 223
13. G.W. Rebeck Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis J. Mol. Neurosci. 23 3 2004 219 224
14. E. Rogaeva The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease Neuromolecular Med. 2 2002 1 10
15. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. St George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, and M.J. Alberts Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
16. G.L. Vega, M.F. Weiner, A.M. Lipton, K. Von Bergmann, D. Lutjohann, C. Moore, and D. Svetlik Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease Arch. Neurol. 60 2003 510 515
17. M.A. Wollmer, J.R. Streffer, D. Lutjohann, M. Tsolaki, V. Iakovidou, T. Hegi, T. Pasch, H.H. Jung, K. Bergmann, R.M. Nitsch, C. Hock, and A. Papassotiropoulos ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease Neurobiol. Aging 24 2003 421 426